ABIONYX Pharma SA

BATS-CHIXE:ABNXP Stock Report

Market Cap: €62.1m

ABIONYX Pharma Ownership

Who are the major shareholders and have insiders been buying or selling?


Recent Insider Transactions

Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.


Ownership Breakdown

What is the ownership structure of ABNXP?
Owner TypeNumber of SharesOwnership Percentage
VC/PE Firms1,630,4515.78%
Institutions1,774,2386.29%
Individual Insiders9,133,29932.4%
General Public15,686,16555.6%

Dilution of Shares: Shareholders have been diluted in the past year, with total shares outstanding growing by 2%.


Top Shareholders

Top 11 shareholders own 44.42% of the company
OwnershipNameSharesCurrent ValueChange %Portfolio %
11.3%
Emmanuel Huynh
3,195,198€7.0m0%no data
6.59%
Sadok Belmokhtar
1,859,098€4.1m0%no data
5.78%
Bpifrance Participations SA
1,630,451€3.6m0%0.03%
5.19%
Cyrille Tupin
1,463,557€3.2m8.77%no data
4.56%
Jean-Louis Dasseux
1,286,781€2.8m0%no data
3.91%
Luc Demarre
1,104,619€2.4m0%no data
3.34%
Odlander, Fredrikson & Co. AB
943,037€2.1m0%1.87%
2.92%
Alta Partners LP
824,701€1.8m0%1.58%
0.74%
Christian Chavy
210,002€462.0k0%no data
0.05%
Laura Coruzzi
14,044€30.9k0%no data
0.023%
Gestys
6,500€14.3k-45.8%0.4%